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1. Introduction 
Recent studies, showing that phentolamine poten- 
tiates the catecholamine-induced cyclic AMP (CAMP) 
accumulation in hamster fat cells [l] , provided 
evidence for the existence of a-adrenergic receptors 
in these cells. Despite this effect, however, phentol- 
amine was recently reported to inhibit catecholamine- 
induced lipolysis in hamster fat cells [2] . 
The present investigation was carried out to further 
characterize the mechanism of this paradoxical action 
of phentolamine. The influence of phentolamine and 
of another a-blocking agent, phenoxybenzamine, on 
the synthesis and release of CAMP, as well as on the 
lipolytic response of hamster fat cells to agents acting 
before and beyond CAMP synthesis, were compared. 
In addition, the previously suggested possibility [3] 
that cyclic GMP (cGMP) metabolism could be sensi- 
tive to a-adrenergic stimulation was also investigated. 
This report shows that the opposite effects of 
phentolamine or phenoxybenzamine on catechol- 
amine-induced CAMP synthesis and lipolysis involve 
two different mechanisms localized before and beyond 
CAMP synthesis, respectively. It shows, furthermore, 
that a-adrenergic stimulation has no influence on the 
cGMP level in hamster adipocytes. 
2. Material and methods 
Epididymal adipose tissue was obtained from fed 
golden hamsters (IRK, Villejuif) weighing 90-l 10 g. 
Adipocytes were isolated following a slight modifica- 
North-Holland Publishing Company - Amsterdam 
tion of the procedure of Hittelman et al. [l] involving 
the suspension of minced pads in Krebs-Ringer 
bicarbonate buffer (pH 7.4) containing 1.27 mM 
calcium and 2% bovine serum albumin. Crude colla- 
genase (1.67 mg/ml) was added for digestion and the 
vials were vigorously shaken in a water bath at 37°C. 
After 7 min digestion, the isolated fat cells were 
separated from the remaining tissue fragments and 
washed as previously described [4] . 
The isolated washed fat cells (50-70 mg cell lipid) 
were suspended in 2 ml of the above-described 
medium with 5 mM glucose added and incubations 
were carried out for different periods at 37°C. Unless 
otherwise stated, all agonists and antagonists were 
added at the start of the incubations. Reactions were 
terminated by separating the fat cells from the 
medium and lipolysis was determined and expressed 
as described [S] . 
Cyclic AMP present in the medium and in the fat 
cells was extracted and determined following the 
radiocompetitive protein-binding assay of Brown et al. 
[6] as described [7] . In order to avoid the possible 
interference of albumin [8] on CAMP determination, 
the blanks and standards used in the assay of CAMP 
released into the medium were carried out on aliquots 
of the incubation buffer. Overall recovery of syn- 
thetic CAMP added to control samples was between 
90% and 95%. Cyclic GMP was extracted and deter- 
mined following the radioimmunological assay of 
Steiner et al. [9] . Under these conditions, even a 
5000-fold CAMP excess over the cGMP content had 
no detectable interference on the assay of cGMP 
whose overall recovery was between 75-80%. 
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Metabolic data are expressed on the basis of fat 
cell lipid dry weight. Results are given as mean values 
f SE and Student’s ‘t’ test was used for comparison 
of mean values. 
Phenoxybenzamine was a preparation from Smith, 
Kline and French and was kindly supplied by Dr 
Mention from the laboratoires Gremy-Longuet . 
Phentolamine was a generous gift from Ciba Pharma- 
ceutical Company. Cyclic [3H] AMP, cyclic [3H]GMP 
and the reagents used in cyclic nucleotide determina- 
tions were purchased from the Radiochemical Centre 
(Amersham). The origin of all other chemicals used 
has been described elsewhere [7]. 
3. Results 
As shown in tig.1, norepinephrine (5 X 10m5 M) 
induced a marked increase in the intracellular CAMP 
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Fig.1. Influence of phentolamine on the time-course of 
norepinephrine-induced cyclic AMP accumulation and release 
in hamster fat cells. After preincubation for 30 min, either 
norepinephrine (5 X 10m5 M) (broken lines) or norepineph- 
rine (5 X 10“ M) plus phentolamine (5 X 10m4 M) 
(solid lines) were added. Cyclic AMP was determined just 
before and at different times after these additions. (n- - -0; 
n -m) Intracellular CAMP; (o- - -0, 0-0) extracellular CAMP: 
(A- - -a; A--)r) total (intra + extracellular) CAMP. Each point 
represents the mean value of 4-8 determinations. 
level which reached a plateau after 30 min incubation. 
At this time, the high levels attained (about 17-fold 
the basal values) far exceeded those usually reported 
in rat fat cells under the present experimental condi- 
tions (absence of phosphodiesterase inhibitor). As 
suggested by Hittelman et al. [l] , most of this peculiar 
high reactivity of hamster adipocytes is related to the 
briefness of the cell isolation procedure used : indeed, 
the CAMP levels found, under the same conditions of 
stimulation, in cells isolated following the method of 
Rodbell [lo] attained only 2.5-3 times the basal 
values (data not shown). 
As expected, phentolamine (5 X lo4 M) enhanced 
the stimulating effect of norepinephrine on CAMP 
synthesis (fig.1). This effect was biphasic: the maximal 
level was reached within the first 10 min (7-8-times 
the level found with norepinephrine alone), after 
which the CAMP content slowly fell and returned 
after 30 min to levels similar to those found with 
norepinephrine alone. Under these conditions, phen- 
tolamine also enhanced the amount of CAMP released 
from the fat cell, showing thus that the modifications 
of CAMP metabolism induced by phentolamine are 
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Fig.2. Influence of phenoxybenzamine on the time-course of 
norepinephrine-induced cyclic AMP accumulation and release 
in hamster fat cells. Experimental conditions and symbols are 
the same as those described in fig.1, except that phenoxybenz- 
amine (5 X 10m4 M) was added in place of phentolamine. 
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Table 1 
Inhibition of norepinephrine-induced lipolysis by phentolamine and phenoxybenzamine in hamster adipocytes 
Addition to 
the medium 
0 
Norepinephrine (5 X lo-” M) 
Norepinephrine (5 X lo-’ M) + 
phentolamine (5 X 10e4 M) 
Norepinephrine (5 X lo-’ M) + 
phenoxybenzamine (5 X 10e4 M) 
Glycerol release 
(pmol. g’ cell lipid. h-‘) 
2.9 f 0.5 
43.5 f 1.6 
4.9 k 0.8 
(P < 0.001) 
28.4 i 1.8 
(P < 0.001) 
Inhibition of norepinephrine- 
induced lipolysisa (%) 
100 
0 
95 
37 
a Defined as = 100-100 (NT-B/N-B), where NT, N and B represent the glycerol released by cells incubated in 
the presence of norepinephrine plus test compounds, in the presence of norepinephrine alone and in the basal 
state, respectively 
Each value is the mean f SE of 5-10 determinations. Statistical significance refers to the results found with 
norepinephrine alone 
not due to an inhibition of the transfer of CAMP from 
the fat cell into the medium. 
When phenoxybenzamine (5 X lOA M) was added 
in place of phentolamine, the norepinephrineinduced 
CAMP accumulation in and out the fat cell also 
increased (tig.2). Although the maximal effect was of 
the same order of magnitude as that induced by 
phentolamine, CAMP accumulation followed a differ- 
ent time-course, the maximal increase occurring 
between 30 min and 60 min incubation. 
Data in table 1 show that both a-adrenolytic drugs 
(5 X lo4 M) caused an inhibition of catecholamine- 
induced lipolysis. Phentolamine was more potent than 
phenoxybenzamine, the rate of inhibition induced 
by both compounds being 95% and 37% respectively. 
Lipolysis stimulated by dibutyryl cyclic AMP (DcAMP) 
(10m3M) was also antagonized by both blocking agents, 
action which was significant with concentrations 
above lo-’ M, in the case of phentolamine (table 2); 
at the concentration of 5 X lo4 M, furthermore, the 
Table 2 
Inhibition of dibutyryl cyclic AMP-induced lipolysis by phentolamine and phenoxybenzamine in 
hamster adipocytes 
Addition to 
the medium 
Glycerol release 
(pmol. g-r cell lipid. h-‘) 
Inhibition of DcAMP- 
induced lipolysis (%) 
0 
DcAMP (1 x 1O-3 M) 
DcAMP (1 x 10-s M) + 
phentolamine (1 X lo-’ M) 
DcAMP (1 X IO-” M) + 
phentolamine (1 X 10e4 M) 
DcAMP (1 X lo-$ M) + 
phentolamine (5 X 10e4 M) 
DcAMP (1 x 10-a M) + 
phenoxybenzamine (5 X 10e4 M) 
3.4 f 0.2 
8.5 r 0.7 
7.2 + 0.9 
(P > 0.05) 
4.8 f 0.7 
(P < 0.001) 
4.6 + 1.0 
(P < 0.001) 
6.1 * 0.9 
(0.001 <P < 0.01) 
100 
0 
25 
73 
76 
47 
Experimental conditions and symbols as in table 1 
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rate of inhibition induced by both blocking agents was 
similar to that found with norepinephrine-induced 
lipolysis. 
The influence of a-adrenergic stimulation and 
inhibition on the cGMP accumulated in and released 
from hamster fat cells was also examined (table 3). 
As can be seen, no significant modification was 
encountered between the cCMP levels found after 
exposure to norepinephrine alone or to norepinephrine 
plus phenoxybenzamine. Moreover, these levels were 
not statistically different from those found in the 
basal state (data not shown). 
4. Discussion 
In fat cells, the first evidence confirming the 
coexistence of functionally opposed CY- and /3-adren- 
ergic receptors as regulatory subunits of adenylate 
cyclase [ 1 l] was obtained with human adipocytes 
[ 121 . However, it was rapidly felt that this concept 
could not be extended to the fat cells of all species 
studied and particularly to the commonly used rat 
fat cells [ 131 . 
Recent studies have shown that hamster white fat 
cells have a peculiar behaviour which set them apart 
from rat adipocytes [l] . Indeed, experiments testing 
the influence of catecholamine and phentolamine on 
CAMP metabolism provided some evidence for the 
existence of a-adrenergic sensitivity in these cells, 
suggesting that hamster adipocytes may be an appro- 
priate model to study some aspects of the hormonal 
control of human fat cells [l] . 
Despite its action upon CAMP synthesis, it was 
recently reported that phentolamine at concentrations 
higher than 5 X lo-’ M inhibits catecholamine- 
induced lipolysis in hamster fat cells [2] . To explain 
this paradoxical effect, we have presently investigated 
and compared the influence of phentolamine and of 
another a-adrenolytic drug, phenoxybenzamine [ 141, 
on both the time-course of norepinephrine-induced 
CAMP synthesis and on some of the lipolytic responses 
of hamster fat cells. 
The present results showing that both drugs increase 
to a similar extent, but with different time-courses, 
the catecholamine-induced CAMP accumulation in and 
release from hamster adipocytes, strengthen the con- 
cept of the existence of a-receptors in these cells. In 
addition, the marked inhibitory effect of phentol- 
amine against norepinephrine-induced lipolysis was 
confirmed [2] , an effect which was also observed, 
although to a slighter extent with phenoxybenzamine. 
This rather low antilipolytic action of phenoxybenz- 
amine could be explained by the peculiar long-lasting 
action of this drug on catecholamineinduced CAMP 
accumulation. In fact, this action still persisted when 
lipolysis was determined, suggesting that phenoxy- 
benzamine, contrarily to phentolamine [13] , may 
inhibit phosphodiesterase. 
On the other hand, this study also shows that when 
used under conditions reported to increase the lipo- 
lytic response of hamster fat cells to catecholamines 
(low concentrations) [2], phentolamine has no signifi- 
cant effect on DcAMP-induced lipolysis. On the 
contrary, at concentrations inhibiting catecholamine- 
stimulated lipolysis, both phentolamine and phenoxy- 
benzamine depress the DcAMP-stimulated one, with 
phentolamine being here again the most potent anta- 
gonist. As DcAMP mimicks the effects of endogenous 
CAMP [ 151 , these data led us to conclude that the 
antagonistic effect of these two a-adrenolytic drugs 
against catecholamine-induced lipolysis is linked to 
their inhibitory action on one of the distal steps of 
the lipolytic process, i.e., CAMP binding to protein 
kinase, protein kinase or triglyceride lipase activation 
[ 161 . Therefore and because of the intracellular 
localization of the latter enzymes [ 161 , it is also 
possible that the rather modest antilipolytic action of 
phenoxybenzamine is linked to a lower fat-cell 
membrane permeability to this compound than to 
phentolamine. 
Finally, the present study also indicates that the 
hypothesis previously formulated [3] , according to 
which a-adrenergic stimulation may increase cCMP, 
is not valid, at least for hamster fat cells. As acetyl- 
choline has been shown to increase the intracellular 
cGMP levels [ 171 , it is therefore likely that the rise 
in plasma cGMP reported by Ball et al. [3] after 
infusion of cy-adrenergic agents is due to the para- 
sympathic stimulation which occurs as a reflexive 
consequence of the pressor effect of a-adrenergic 
stimulation rather than to a direct response to 
a-adrenergic activity. 
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